Cytovance Biologics, a premier biopharmaceutical CDMO of mammalian and microbial biologics, is proud to announce the appointment of Ping Zhang as its new Chief Executive Officer. With a Master of Business Administration and board experience in the Hepalink Group, Mr. Zhang brings a wealth of knowledge and a strategic outlook to the company’s contract manufacturing operations. His leadership will be integral to the development and execution of Cytovance’s ambitious business strategies.
With more than three decades of experience in the pharmaceutical industry, Mr. Zhang has held several prestigious positions. He spent 20 years as Head of Industry Affairs China at Sanofi, overseeing seven plants across China, and was responsible for technical transfers and new product launches. Prior to that, he was Head of Manufacturing at Johnson & Johnson China for 14 years. Mr. Zhang’s impressive career speaks for itself.
At Cytovance, our mission is to empower and enable a healthier, safer, and better world through our biologics CDMO services. For over two decades, we have been providing innovative and reliable solutions to our customers, ultimately contributing to the improved health and well-being of countless individuals. Driven by this responsibility, we remain committed to delivering the highest quality products and services with an unwavering focus on customer value.
About Cytovance® Biologics
At Cytovance Biologics, we specialize in the rapid and cost-effective development and manufacture of large molecule active pharmaceutical ingredients (APIs) from mammalian cell culture and microbial fermentation. Our comprehensive services include cell line and microbial strain development, process and analytical development, process characterization, raw materials management, QC testing, ICH stability studies, and regulatory support. Our 140,000 sq. ft. state-of-the-art facilities are designed to meet U.S., EU, and other global regulatory standards, ensuring that all of our products are of the highest quality. With our expertise, your project will be in the safe hands of our experienced and knowledgeable program management team. Let us help you bring your life-changing therapies to market.
At Cytovance, we provide customized services for the scale-up and CGMP manufacture of protein-based therapeutics. Our deep industry expertise covers everything from pre-clinical development in the early stages, to commercial production for both mammalian and microbial.